全文获取类型
收费全文 | 10497篇 |
免费 | 2766篇 |
国内免费 | 242篇 |
专业分类
耳鼻咽喉 | 659篇 |
儿科学 | 283篇 |
妇产科学 | 227篇 |
基础医学 | 181篇 |
口腔科学 | 319篇 |
临床医学 | 1681篇 |
内科学 | 2470篇 |
皮肤病学 | 525篇 |
神经病学 | 1169篇 |
特种医学 | 526篇 |
外科学 | 3086篇 |
综合类 | 42篇 |
现状与发展 | 2篇 |
预防医学 | 784篇 |
眼科学 | 352篇 |
药学 | 88篇 |
中国医学 | 1篇 |
肿瘤学 | 1110篇 |
出版年
2024年 | 96篇 |
2023年 | 508篇 |
2022年 | 141篇 |
2021年 | 293篇 |
2020年 | 729篇 |
2019年 | 211篇 |
2018年 | 655篇 |
2017年 | 624篇 |
2016年 | 781篇 |
2015年 | 695篇 |
2014年 | 945篇 |
2013年 | 1051篇 |
2012年 | 333篇 |
2011年 | 271篇 |
2010年 | 630篇 |
2009年 | 848篇 |
2008年 | 315篇 |
2007年 | 194篇 |
2006年 | 292篇 |
2005年 | 168篇 |
2004年 | 118篇 |
2003年 | 97篇 |
2002年 | 93篇 |
2001年 | 173篇 |
2000年 | 107篇 |
1999年 | 170篇 |
1998年 | 252篇 |
1997年 | 271篇 |
1996年 | 317篇 |
1995年 | 286篇 |
1994年 | 178篇 |
1993年 | 128篇 |
1992年 | 132篇 |
1991年 | 131篇 |
1990年 | 69篇 |
1989年 | 125篇 |
1988年 | 98篇 |
1987年 | 77篇 |
1986年 | 86篇 |
1985年 | 86篇 |
1984年 | 86篇 |
1983年 | 69篇 |
1982年 | 74篇 |
1981年 | 49篇 |
1980年 | 53篇 |
1978年 | 45篇 |
1977年 | 45篇 |
1976年 | 31篇 |
1975年 | 43篇 |
1972年 | 31篇 |
排序方式: 共有10000条查询结果,搜索用时 31 毫秒
111.
Twenty-seven patients with idiopathic palmoplanter hyperhidrosis were treated with Iontotherapy over a one year period. In twenty-four cases there was a good response but maintenance therapy was required every 3-4 weeks.KEY WORDS: Iontophoresis, Palmoplanter hyperhidrosis 相似文献
112.
113.
Cancer Incidence in Kentucky, Pennsylvania, and West Virginia: Disparities in Appalachia 总被引:7,自引:0,他引:7
Eugene J. Lengerich VMD MS ; Thomas C. Tucker PhD MPH ; Raymond K. Powell MPH ; Pat Colsher PhD ; Erik Lehman MS ; Ann J. Ward MS ; Jennifer C. Siedlecki BS ; Stephen W. Wyatt DMD MPH 《The Journal of rural health》2005,21(1):39-47
CONTEXT: Composed of all or a portion of 13 states, Appalachia is a heterogeneous, economically disadvantaged region of the eastern United States. While mortality from cancer in Appalachia has previously been reported to be elevated, rates of cancer incidence in Appalachia remain unreported. PURPOSE: To estimate Appalachian cancer incidence by stage and site and to determine if incidence was greater than that in the United States. METHODS: Using 1994--1998 data from the central registries of Kentucky, Pennsylvania, and West Virginia, age-adjusted incidence rates were calculated for the rural and nonrural regions of Appalachia. These state rates were compared to rates from the Surveillance, Epidemiology, and End Results (SEER) program for the same years by calculating the adjusted rate ratio (RR) and a 95% confidence interval (CI). FINDINGS: Both the entire and rural Appalachian regions had an adjusted incidence rate for all cancer sites similar to the SEER rate (RR = 1.00 [95% CI, 1.00-1.01] and RR = 0.99 [95% CI, 0.99-1.00], respectively). However, incidence of cancer of the lung/ bronchus, colon, rectum, and cervix in Appalachia was significantly elevated (RR = 1.22 [95% CI, 1.20-1.23], 1.13 [95% CI, 1.11-1.14], 1.19 [95% CI, 1.16-1.22], and 1.12 [95% CI, 1.07-1.17], respectively). Incidence of cancer of the lung/bronchus and cervix in rural Appalachia was even more elevated (RR = 1.34 [95% CI, 1.31-1.36] and 1.29 [95% CI, 1.21-1.38], respectively). Incidence of unstaged disease for all cancer sites in Appalachia (RR = 1.06 [95% CI, 1.05-1.08]), particularly rural Appalachia (RR = 1.28 [95%CI, 1.25-1.301), was elevated. CONCLUSIONS: Cancer incidence in Appalachia was not found to be elevated. However, incidence of cancer of the lung/bronchus, colon, rectum, and cervix was elevated in Appalachia. The rates of unstaged cancer of every examined site were elevated in rural Appalachia, suggesting a lack of access to cancer health care. 相似文献
114.
J. Jaime Caro MDCM K. Jack Ishak MSc Ingrid Caro MEd Kristen Migliaccio-Walle BS Wendy S. Klittich BS 《Value in health》2004,7(5):585-594
OBJECTIVES: Clinicians are told to use the number needed to treat (NNT) to compare the benefits of therapeutic strategies, and researchers are asked to report results this way, generally without considering differences among the studies from which these were derived. METHODS: The crude NNT currently advocated is compared to the NNT standardized for a common outcome, follow-up time, study population and comparator. An NNT model for cardiovascular disease is described as an example that addresses differences among studies of secondary prevention of cardiovascular disease. Crude NNTs are compared to those obtained from the model. RESULTS: Follow-up in the 18 trials identified varied from 1.0 to 6.2 years; rates of cardiovascular events in the untreated subgroups ranged from 4.8% to 45.9%. The crude NNTs were more variable (9.1-163.7) than those obtained from the model (9.1-75.2). The effect of standardization was substantial in some cases, with proportional changes ranging from a 91% decrease to a 223% increase. CONCLUSION: Using an NNT model to account for differences in study design allows for more meaningful comparisons. 相似文献
115.
116.
117.
118.
119.
120.